UC-San Diego: Repurposed Arthritis Drug Did Not Significantly Improve Severe COVID-19 Pneumonia
March 02, 2021
March 02, 2021
LA JOLLA, California, March 2 (TNSJou) -- The University of California San Diego campus issued the following news:
In a study published online February 25, 2021 in The New England Journal of Medicine, a repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia.
Results of the Phase III clinical trial, conducted by an international team led by senior author Atul Malhotra, MD, research chief of pulmonary, . . .
In a study published online February 25, 2021 in The New England Journal of Medicine, a repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia.
Results of the Phase III clinical trial, conducted by an international team led by senior author Atul Malhotra, MD, research chief of pulmonary, . . .